GENEVA (AP) -- Swiss pharmaceuticals giant Novartis says it has agreed to buy the U.S.-based gene therapy company AveXis Inc. for $8.7 billion, part of its goal to become a leader in the treatment of neurodegenerative diseases....


80


AP

15 Related Articles, between 2018-02-16 and 2018-03-28